Skip to content
Clinical Trials – home

Morphine Sulfate: A Comprehensive Guide for Patients

7 / 8
trials open to patients / all trials
3+
Countries

In short

Morphine Sulfate, a powerful opioid pain medication, has been the subject of numerous clinical trials to assess its safety, efficacy, and pharmacokinetics in various patient populations. These studies aim to improve our understanding of how Morphine Sulfate works in different formulations, dosages, and patient groups, including those with specific conditions like obstructive sleep apnea, cancer pain, and postoperative pain. The trials also explore the drug's interactions with food and alcohol, as well as its use in pediatric patients.

At a glance

Study Types
Bioequivalence, pharmacokinetics, safety, efficacy
Patient Populations
Healthy volunteers, cancer patients, postoperative patients, pediatric patients (2-17 years)
Formulations Studied
Immediate-release tablets, extended-release tablets, oral solutions, controlled-release capsules
Key Outcomes Measured
Pharmacokinetic parameters (Cmax, AUC, Tmax), adverse events, pain control, respiratory function
Special Considerations
Food effects, alcohol interactions, use in obstructive sleep apnea patients
Safety Monitoring
Adverse events, sedation levels, respiratory depression, vital signs

What is Morphine Sulfate?

Morphine Sulfate is a powerful pain-relieving medication that belongs to the opioid class of drugs. It is commonly used to treat moderate to severe pain in various medical situations. Morphine Sulfate is known by several other names, including MS Contin, Roxanol, Kadian, and Avinza. These different names often refer to various formulations or brand names of the same active ingredient.

Uses of Morphine Sulfate

Morphine Sulfate is primarily used for pain management in several conditions:

  • Post-operative pain: It is commonly used to control pain after surgical procedures, especially in cases like laparoscopic sigmoidectomy (a type of colon surgery).
  • Acute pain: It can be used in emergency departments to manage severe acute pain, such as in cases of abdominal pain, flank/lumbar back pain, or pain in the extremities.
  • Fracture pain: Morphine can be used to manage pain associated with fractures, particularly proximal femur (hip) fractures.
  • Cancer-related pain: While not explicitly mentioned in the provided studies, morphine is widely used in cancer pain management.

How Morphine Sulfate Works

Morphine Sulfate works by binding to specific receptors in the brain and spinal cord called opioid receptors. This binding action changes how the body perceives pain, effectively reducing the sensation of pain. It also can produce feelings of euphoria and relaxation, which is why it's classified as a controlled substance.

Administration Methods

Morphine Sulfate can be administered in several ways:

  • Intravenous (IV): Directly into a vein, often used in hospital settings for quick pain relief.
  • Patient-Controlled Analgesia (PCA): A method where the patient can self-administer small doses of morphine through an IV line as needed.
  • Oral solution: A liquid form that can be taken by mouth.
  • Extended-release tablets: Pills designed to release the medication slowly over time.

Effectiveness in Pain Management

Morphine Sulfate is considered highly effective for pain management. Studies have shown its efficacy in various scenarios:

  • In post-operative pain management after procedures like laparoscopic sigmoidectomy, morphine has been compared to other pain management techniques such as epidural anesthesia and nerve blocks.
  • For acute pain in emergency settings, morphine has been studied against other pain management options like low-dose ketamine.
  • In cases of proximal femur fractures, morphine infusion has been compared to nerve block techniques for pain control.

Side Effects and Precautions

While Morphine Sulfate is effective for pain management, it does come with potential side effects and risks:

  • Respiratory depression: Morphine can slow down breathing, which is a particular concern in patients with sleep apnea.
  • Nausea and vomiting: These are common side effects, often managed with anti-nausea medications.
  • Sedation: Morphine can cause drowsiness and affect alertness.
  • Constipation: Opioids like morphine can slow down bowel function.
  • Risk of dependence: Long-term use of morphine can lead to physical dependence and addiction.

Special precautions are needed when using morphine in certain patient groups, such as those with sleep apnea or respiratory conditions.

Ongoing Research

Research on Morphine Sulfate is ongoing to better understand its effects and optimize its use:

  • Studies are being conducted to compare morphine with other pain management techniques, such as nerve blocks, for specific types of pain.
  • Research is examining the effects of morphine on sleep-disordered breathing in patients with obstructive sleep apnea.
  • Investigations are ongoing into different formulations of morphine, such as extended-release tablets, to improve its effectiveness and reduce side effects.

Questions people often ask

Conditions where Morphine Sulfate is being studied

Each condition opens its own overview and trial list

Trials with Morphine Sulfate

Recruiting trials first

See all 8 →
Quick filters
  • Participants:Adults
  • Participants:Children
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).